Status:
COMPLETED
Adherence to Lumefantrine-Artemether
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Ifakara Health Research and Development Centre
Conditions:
Malaria, Uncomplicated
Eligibility:
All Genders
Up to 59 years
Brief Summary
This is a study of how well caregivers of children with malaria adhere to the recommended regimen for lumefantrine-artemether (LA). Children were randomly assigned to either a group receiving directly...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- age \< 5 years of age.
- axillary temperature \>= 37.5oC
- unmixed infection with P. falciparum of between 1,000 and 250,000 asexual parasites/mm3 as determined by microscopic examination of thick, or thick and thin peripheral blood smears.
- parent/guardian's informed consent and willingness to participate in the study
- Exclusion criteria:
- any evidence of severe or complicated malaria that would require hospitalization for treatment.
- reported allergy to any antimalarial drugs, including artemisinin derivatives and sulfa drugs.
Exclusion
Key Trial Info
Start Date :
August 1 2002
Trial Type :
OBSERVATIONAL
End Date :
August 1 2006
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00153491
Start Date
August 1 2002
End Date
August 1 2006
Last Update
September 12 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mkuranga District Hospital
Mkwanga, Mkuranga District, Tanzania